Polymorphism of the Aromatase Enzyme Gene at the rs700519 Site and Its Relationship with Some Biochemical Variables in Women with Polycystic Ovary Syndrome
DOI:
https://doi.org/10.36371/port.2023.1.4Authors
Polycystic Ovary Syndrome (PCOS) is identified as one of the most common hormonal disturbances that can affect females in their reproductive period, having significant implications on fertility observable during the reproductive span and post-menopause (Hanan et al., 2020). This study was designed to decipher the relationship between PCOS and the polymorphism of the aromatase gene at the rs700519 locus along with certain biochemical variables. The research comprised 50 blood samples from women afflicted with PCOS and 25 samples from non-afflicted women, spanning an age range of 16 to 45 years. Additionally, the study involved exploring the polymorphisms of the aromatase gene (CYP19A1) concerning SNPs rs700519 in both afflicted and non-afflicted women. The electrophoretic analysis of the PCR product on a 1% agarose gel for the aromatase gene (CYP19A1) indicated the presence of three genetic patterns (GG, GA, AA). The allele frequency for the aromatase gene SNP CYP19A1 (rs700519) in women with and without PCOS revealed values of 0.49 and 0.54 for the G allele, and 0.51 and 0.46 for the A allele, respectively. The genetic patterns did not exhibit any significant predisposition, with an Odds Ratio (OR) of 0.818 for the mutant A allele at the CYP19A1 rs700519 locus
Keywords:
SNP, Aromatase gene, Prl, Testo, PCOS[1] Diamanti - Kandarakis , E. ( 2008 ). Polycystic ovarian syndrome : Patho- physiology, molecular aspects and clinical implications . Cambridge university press . Expert reviews in molecular. 10 : 1- 15.
[2] Deswal, R., Narwal, V., Dang, A., Pundir, C.S. (2020). The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci 13(4):261–271.
[3] Carrie Riestenberg, Anika Jagasia, Daniela Markovic, Richard P Buyalos, and Ricardo Azziz.(2022). Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences, The Journal of Clinical Endocrinology & Metabolism, 107, (2): 575–585.
[4] Teede, H., Deeks, A., & Moran, L. (2010). Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC medicine, 8(1), 41.
[5] Trikudanathan S (2015) Polycystic ovarian syndrome. Med Clin North Am 99(1): 221-235.
[6] Barnard B , ; Ferriday, D. ; Guenther, N .; Strauss, B .; Balen, A,and Dye , L . (2007) . Quality of life and psychological well being in polycystic ovary syndrome. Hum . Keprod . 22(8) : 2279 -2286 .
[7] Scott kahan, RedondaMiller, Ellen G.Smith .2009.IN A page signs and symptoms second edition .wolters Kluwer .united states of America.
[8] Kristensen SL, Ramlau-Hansen CH, Ernst E. (2010) ,A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed? Hum Reprod.;25-22.
[9] Deeks ,A.A ., Gibson-Helm, ME ., Paul, E., Teede, HJ. (2011).Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. Jun;26(6):1399-407. doi: 10.1093/humrep/der071. Epub 2011 Mar 23. PMID: 21436137.
[10] Nebert DW, Nelson DR, Adesnik M, Coon MJ, Estabrook RW, Gonzalez FJ et al. The P450 gene superfamily: recommended nomenclature. DNA 1989 8 1 – 13.
[11] Joseph SBR , Bhujbalrao R, Idicula-Thomas S. PCOSKB: a KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic Ovary Syndrome. Nucl Acids Res 2015.
[12] Al-Tikriti, Rasul Hisham Taha, 2022. "Unequal Association of Polymorphic Variants of Androgen Receptor-Encoded Genes and Sex Hormone-Binding Globulin with Various Biochemical Variables in Women Affected with Polycystic Ovary Syndrome in Salah al-Din Province." Master's Thesis, Faculty of Science, Tikrit University.
[13] Anderson, J. L., King, G. J., Bair, T. L., Elmer, S. P., Muhlestein, J. B., Habashi, J., ... & Carlquist, J. F. (1999). Association of lipoprotein lipase gene polymorphisms with coronary artery disease. Journal of the American College of Cardiology, 33(4), 1013-1020.];[.lp-l]
[14] Khan, M.J., Ullah, A., Basit., S. (2019). Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives. Application clinical genetics. 12,249-260.
[15] Hylactou M, Clarke SA, Patel B, (2020): Clinical and biochemical discriminants between functional hypothalamic amenorrhea (FHA)and polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2020; 95:239‐252.
[16] Crosignani, P. G., & Nicolosi, A. E. (2001). Polycystic ovarian disease: heritability and heterogeneity. Human reproduction update, 7(1), 3-7.
[17] Palioura, E., & Diamanti-Kandarakis, E. (2013). Industrial endocrine disruptors and polycystic ovary syndrome. Journal of endocrinological investigation, 36(11), 1105-1111.
[18] Pasquali, R., Zanotti, L., Fanelli, F., Mezzullo, M., Fazzini, A., Morselli Labate, A. M., ... & Gambineri, A. (2016). Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective. The Journal of Clinical Endocrinology & Metabolism, 101(5), 2013-2022.16-Chen, Shen, Tan, Xia, Xia, Cao, Wang, Wu, Wang, Yi, Gao & Yong, (2015). The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome, Journal of ovarian research, 8(1), 11-16.
License
Copyright (c) 2023 Journal Port Science Research

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Downloads
- Published: 2023-10-10
- Issue: Vol. 6 No. 1 (2023): APPLIED MEDICAL SCIENCE
- Section: Articles